Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways
- DOI
- 10.1093/ajh/hpag111
- Published
- 2026-09-08
- Container
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ajh/hpag111,
title = {Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways},
author = {Sriram Sriperumbuduri and Rachel W Khan and Soyeb Aftab and Swapnil Hiremath and Dave Dixon and Gaurav Gupta},
year = {2026},
journal = {American Journal of Hypertension},
doi = {10.1093/ajh/hpag111},
url = {https://doi.org/10.1093/ajh/hpag111}
}RIS
TY - JOUR TI - Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways AU - Sriram Sriperumbuduri AU - Rachel W Khan AU - Soyeb Aftab AU - Swapnil Hiremath AU - Dave Dixon AU - Gaurav Gupta PY - 2026 JO - American Journal of Hypertension DO - 10.1093/ajh/hpag111 UR - https://doi.org/10.1093/ajh/hpag111 ER -
APA
Sriperumbuduri, S., Khan, R. W., Aftab, S., Hiremath, S., Dixon, D., & Gupta, G. (2026). Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag111
Source records
- crossref · retrieved 2026-09-26T12:52:41.978Z